CLINICAL_TRIALS
trial_result
· 2014-09-01
Clinical Trial Update: Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis [Phase 2]
Summary
Phase 2 clinical trial update on neurogenic detrusor overactivity after spinal cord injury or multiple sclerosis; results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ipsen | Conditions: Detrusor Muscle Hyperactivity | Phase 2 | Status: COMPLETED | Results posted: 2014-09-01